Joseph Schwartz's Stock Ratings

Leerink Partners Analyst

Joseph Schwartz is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/18/2025

Overall Average Return

17.0%

Smart Score

64.4%

Overall Average Return Percentile

75th

Number of Ratings

188
Buy NowGet Alert
06/10/2025INSMBuy Now
Insmed
$99.4615.62%
Joseph Schwartz64%
$100 → $115MaintainsOutperformGet Alert
05/23/2025FULCBuy Now
Fulcrum Therapeutics
$6.8076.47%
Joseph Schwartz64%
$4 → $12UpgradeMarket Perform → OutperformGet Alert
04/30/2025RGLSBuy Now
Regulus Therapeutics
$8.21-14.74%
Joseph Schwartz64%
→ $7DowngradeOutperform → Market PerformGet Alert
02/25/2025MAZEBuy Now
Maze Therapeutics
$12.39125.99%
Joseph Schwartz64%
→ $28Initiates → OutperformGet Alert
10/11/2024TVTXBuy Now
Travere Therapeutics
$13.93187.15%
Joseph Schwartz64%
$20 → $40MaintainsOutperformGet Alert
10/08/2024TVTXBuy Now
Travere Therapeutics
$13.9343.58%
Joseph Schwartz64%
$20 → $20ReiteratesOutperform → OutperformGet Alert
09/19/2024APLTBuy Now
Applied Therapeutics
$0.363788.89%
Joseph Schwartz64%
$11 → $14MaintainsOutperformGet Alert
09/12/2024FULCBuy Now
Fulcrum Therapeutics
$6.80-41.18%
Joseph Schwartz64%
→ $4DowngradeOutperform → Market PerformGet Alert
07/03/2024ANTXBuy Now
AN2 Therapeutics
$1.08—
Joseph Schwartz64%
—UpgradeMarket Perform → OutperformGet Alert
06/24/2024SLDBBuy Now
Solid Biosciences
$4.80150%
Joseph Schwartz64%
$12 → $12UpgradeMarket Perform → OutperformGet Alert
06/20/2024MREOBuy Now
Mereo BioPharma Group
$2.88177.78%
Joseph Schwartz64%
$6 → $8MaintainsOutperformGet Alert
03/18/2024RGLSBuy Now
Regulus Therapeutics
$8.21-26.92%
Joseph Schwartz64%
→ $6Initiates → OutperformGet Alert
03/14/2024SPRBBuy Now
Spruce Biosciences
$0.082400%
Joseph Schwartz64%
$9 → $2DowngradeOutperform → Market PerformGet Alert
02/22/2024APLTBuy Now
Applied Therapeutics
$0.363233.33%
Joseph Schwartz64%
→ $12Initiates → OutperformGet Alert
02/13/2024ANTXBuy Now
AN2 Therapeutics
$1.08548.15%
Joseph Schwartz64%
$23 → $7DowngradeOutperform → Market PerformGet Alert
02/09/2024SYBXBuy Now
Synlogic
$1.21-17.36%
Joseph Schwartz64%
→ $1DowngradeOutperform → Market PerformGet Alert
12/15/2023RPHMBuy Now
Reneo Pharmaceuticals
——
Joseph Schwartz64%
→ $1DowngradeOutperform → Market PerformGet Alert
09/08/2023SPRBBuy Now
Spruce Biosciences
$0.0811150%
Joseph Schwartz64%
$3 → $9UpgradeMarket Perform → OutperformGet Alert
08/18/2023SELBBuy Now
Selecta Biosciences
——
Joseph Schwartz64%
→ $1DowngradeOutperform → Market PerformGet Alert
08/15/2023DSGNBuy Now
Design Therapeutics
$3.9452.28%
Joseph Schwartz64%
→ $6DowngradeOutperform → Market PerformGet Alert
06/13/2023KDNYBuy Now
Chinook Therapeutics
——
Joseph Schwartz64%
$44 → $40DowngradeOutperform → Market PerformGet Alert
06/12/2023RETABuy Now
Reata Pharmaceuticals
——
Joseph Schwartz64%
$80 → $115UpgradeMarket Perform → OutperformGet Alert
03/17/2023PTCTBuy Now
PTC Therapeutics
$49.60-3.23%
Joseph Schwartz64%
→ $48Initiates → Market PerformGet Alert
02/03/2023PHVSBuy Now
Pharvaris
$16.568.7%
Joseph Schwartz64%
$20 → $18MaintainsOutperformGet Alert
02/03/2023KALVBuy Now
KalVista Pharma
$12.3362.21%
Joseph Schwartz64%
$30 → $20MaintainsOutperformGet Alert
02/03/2023IONSBuy Now
Ionis Pharmaceuticals
$37.02-8.16%
Joseph Schwartz64%
$33 → $34MaintainsMarket PerformGet Alert
02/03/2023BMRNBuy Now
Biomarin Pharmaceutical
$55.28135.17%
Joseph Schwartz64%
$122 → $130MaintainsOutperformGet Alert
01/20/2023SRPTBuy Now
Sarepta Therapeutics
$20.65674.82%
Joseph Schwartz64%
→ $160Reiterates → OutperformGet Alert
01/17/2023ASNDBuy Now
Ascendis Pharma
$170.71-4.52%
Joseph Schwartz64%
$148 → $163MaintainsOutperformGet Alert
12/27/2022AMTIBuy Now
Applied Molecular
——
Joseph Schwartz64%
$15 → $2DowngradeOutperform → Market PerformGet Alert
12/09/2022DSGNBuy Now
Design Therapeutics
$3.94458.38%
Joseph Schwartz64%
$30 → $22MaintainsOutperformGet Alert
12/07/2022GOSSBuy Now
Gossamer Bio
$1.29675.19%
Joseph Schwartz64%
$15 → $10MaintainsOutperformGet Alert
11/14/2022ASNDBuy Now
Ascendis Pharma
$170.71-13.3%
Joseph Schwartz64%
$168 → $148MaintainsOutperformGet Alert
11/14/2022ANTXBuy Now
AN2 Therapeutics
$1.082214.81%
Joseph Schwartz64%
$27 → $25MaintainsOutperformGet Alert
11/10/2022SLDBBuy Now
Solid Biosciences
$4.8025%
Joseph Schwartz64%
$1 → $6MaintainsMarket PerformGet Alert
11/10/2022PEPGBuy Now
PepGen
$1.462159.96%
Joseph Schwartz64%
$40 → $33MaintainsOutperformGet Alert
11/10/2022MREOBuy Now
Mereo BioPharma Group
$2.8838.89%
Joseph Schwartz64%
$8 → $4MaintainsOutperformGet Alert
11/08/2022AMTIBuy Now
Applied Molecular
——
Joseph Schwartz64%
$21 → $15MaintainsOutperformGet Alert
11/04/2022AUPHBuy Now
Aurinia Pharmaceuticals
$7.9251.52%
Joseph Schwartz64%
$17 → $12MaintainsOutperformGet Alert
11/03/2022RAREBuy Now
Ultragenyx Pharmaceutical
$37.35189.16%
Joseph Schwartz64%
$115 → $108MaintainsOutperformGet Alert
10/27/2022INSMBuy Now
Insmed
$99.46-49.73%
Joseph Schwartz64%
$52 → $50MaintainsOutperformGet Alert
10/20/2022TVTXBuy Now
Travere Therapeutics
$13.93172.79%
Joseph Schwartz64%
$45 → $38MaintainsOutperformGet Alert
10/17/2022SLDBBuy Now
Solid Biosciences
$4.80-79.17%
Joseph Schwartz64%
$12 → $1DowngradeOutperform → Market PerformGet Alert
10/17/2022SRPTBuy Now
Sarepta Therapeutics
$20.65602.18%
Joseph Schwartz64%
$126 → $145MaintainsOutperformGet Alert
10/05/2022KALVBuy Now
KalVista Pharma
$12.33143.31%
Joseph Schwartz64%
$45 → $30MaintainsOutperformGet Alert
09/14/2022PHVSBuy Now
Pharvaris
$16.5620.77%
Joseph Schwartz64%
$25 → $20MaintainsOutperformGet Alert
08/23/2022PHVSBuy Now
Pharvaris
$16.5650.97%
Joseph Schwartz64%
$45 → $25MaintainsOutperformGet Alert
08/11/2022ASNDBuy Now
Ascendis Pharma
$170.71-1.59%
Joseph Schwartz64%
$174 → $168MaintainsOutperformGet Alert
08/05/2022TVTXBuy Now
Travere Therapeutics
$13.93223.04%
Joseph Schwartz64%
$42 → $45MaintainsOutperformGet Alert
08/05/2022CCXIBuy Now
ChemoCentryx
——
Joseph Schwartz64%
$64 → $52DowngradeOutperform → Market PerformGet Alert
08/04/2022BMRNBuy Now
Biomarin Pharmaceutical
$55.28120.69%
Joseph Schwartz64%
$115 → $122MaintainsOutperformGet Alert
07/08/2022KALVBuy Now
KalVista Pharma
$12.33264.96%
Joseph Schwartz64%
$51 → $45MaintainsOutperformGet Alert
06/06/2022SELBBuy Now
Selecta Biosciences
——
Joseph Schwartz64%
→ $7Initiates → OutperformGet Alert
05/31/2022PEPGBuy Now
PepGen
$1.462639.35%
Joseph Schwartz64%
→ $40Initiates → OutperformGet Alert
05/26/2022CRNXBuy Now
Crinetics Pharmaceuticals
$30.5027.87%
Joseph Schwartz64%
$36 → $39MaintainsOutperformGet Alert
05/23/2022KDNYBuy Now
Chinook Therapeutics
——
Joseph Schwartz64%
$38 → $44MaintainsOutperformGet Alert
05/20/2022AMTIBuy Now
Applied Molecular
——
Joseph Schwartz64%
$60 → $21MaintainsOutperformGet Alert
05/12/2022IFRXBuy Now
InflaRx
$0.77419.14%
Joseph Schwartz64%
$6 → $4MaintainsOutperformGet Alert
05/12/2022EWTXBuy Now
Edgewise Therapeutics
$14.47107.33%
Joseph Schwartz64%
$34 → $30MaintainsOutperformGet Alert
05/12/2022ASNDBuy Now
Ascendis Pharma
$170.711.93%
Joseph Schwartz64%
$193 → $174MaintainsOutperformGet Alert
05/11/2022GOSSBuy Now
Gossamer Bio
$1.291062.79%
Joseph Schwartz64%
$16 → $15MaintainsOutperformGet Alert
05/11/2022RNABuy Now
Avidity Biosciences
$28.8973.07%
Joseph Schwartz64%
$53 → $50MaintainsOutperformGet Alert
05/10/2022DSGNBuy Now
Design Therapeutics
$3.94661.42%
Joseph Schwartz64%
$36 → $30MaintainsOutperformGet Alert
05/10/2022AMTIBuy Now
Applied Molecular
——
Joseph Schwartz64%
$74 → $60MaintainsOutperformGet Alert
05/06/2022RAREBuy Now
Ultragenyx Pharmaceutical
$37.35207.9%
Joseph Schwartz64%
$178 → $115MaintainsOutperformGet Alert
05/05/2022PTGXBuy Now
Protagonist Therapeutics
$53.92-44.36%
Joseph Schwartz64%
$50 → $30MaintainsOutperformGet Alert
05/03/2022QUREBuy Now
uniQure
$14.50286.21%
Joseph Schwartz64%
$71 → $56MaintainsOutperformGet Alert
04/28/2022SLDBBuy Now
Solid Biosciences
$4.80212.5%
Joseph Schwartz64%
$12 → $15MaintainsOutperformGet Alert
04/06/2022IMRABuy Now
Imara
——
Joseph Schwartz64%
$31 → $1DowngradeOutperform → Market PerformGet Alert
03/30/2022PHVSBuy Now
Pharvaris
$16.56171.74%
Joseph Schwartz64%
$50 → $45MaintainsOutperformGet Alert
03/25/2022IFRXBuy Now
InflaRx
$0.77678.72%
Joseph Schwartz64%
$8 → $6MaintainsOutperformGet Alert
03/24/2022RPHMBuy Now
Reneo Pharmaceuticals
——
Joseph Schwartz64%
$25 → $15MaintainsOutperformGet Alert
03/18/2022SYBXBuy Now
Synlogic
$1.21561.16%
Joseph Schwartz64%
$11 → $8MaintainsOutperformGet Alert
03/16/2022SPRBBuy Now
Spruce Biosciences
$0.083650%
Joseph Schwartz64%
$5 → $3MaintainsMarket PerformGet Alert
03/16/2022IMRABuy Now
Imara
——
Joseph Schwartz64%
$37 → $31MaintainsOutperformGet Alert
03/15/2022ASNDBuy Now
Ascendis Pharma
$170.7113.06%
Joseph Schwartz64%
$190 → $193MaintainsOutperformGet Alert
03/08/2022AUPHBuy Now
Aurinia Pharmaceuticals
$7.92177.78%
Joseph Schwartz64%
$30 → $22MaintainsOutperformGet Alert
02/24/2022FOLDBuy Now
Amicus Therapeutics
$5.73144.33%
Joseph Schwartz64%
$16 → $14MaintainsOutperformGet Alert
02/22/2022INSMBuy Now
Insmed
$99.46-47.72%
Joseph Schwartz64%
$57 → $52MaintainsOutperformGet Alert
01/14/2022FOLDBuy Now
Amicus Therapeutics
$5.73179.23%
Joseph Schwartz64%
$12 → $16UpgradeMarket Perform → OutperformGet Alert
12/16/2021TVTXBuy Now
Travere Therapeutics
$13.93201.51%
Joseph Schwartz64%
$37 → $42MaintainsOutperformGet Alert
12/14/2021ARNABuy Now
Arena Pharmaceuticals
——
Joseph Schwartz64%
$112 → $100DowngradeOutperform → Market PerformGet Alert
12/10/2021RNABuy Now
Avidity Biosciences
$28.8983.45%
Joseph Schwartz64%
$36 → $53MaintainsOutperformGet Alert
12/09/2021RETABuy Now
Reata Pharmaceuticals
——
Joseph Schwartz64%
$282 → $35DowngradeOutperform → Market PerformGet Alert
11/22/2021BMRNBuy Now
Biomarin Pharmaceutical
$55.28108.03%
Joseph Schwartz64%
$112 → $115MaintainsOutperformGet Alert
11/16/2021SPRBBuy Now
Spruce Biosciences
$0.086150%
Joseph Schwartz64%
$35 → $5DowngradeOutperform → Market PerformGet Alert
11/15/2021ASNDBuy Now
Ascendis Pharma
$170.7111.3%
Joseph Schwartz64%
$182 → $190MaintainsOutperformGet Alert
11/15/2021BMRNBuy Now
Biomarin Pharmaceutical
$55.28102.6%
Joseph Schwartz64%
$108 → $112MaintainsOutperformGet Alert
11/11/2021SYBXBuy Now
Synlogic
$1.21809.09%
Joseph Schwartz64%
$15 → $11MaintainsOutperformGet Alert
11/09/2021GOSSBuy Now
Gossamer Bio
$1.291140.31%
Joseph Schwartz64%
$15 → $16MaintainsOutperformGet Alert
11/04/2021AUPHBuy Now
Aurinia Pharmaceuticals
$7.92341.92%
Joseph Schwartz64%
$28 → $35MaintainsOutperformGet Alert
10/12/2021PTGXBuy Now
Protagonist Therapeutics
$53.92-7.27%
Joseph Schwartz64%
$35 → $50MaintainsOutperformGet Alert
10/11/2021CCXIBuy Now
ChemoCentryx
——
Joseph Schwartz64%
$17 → $64UpgradeMarket Perform → OutperformGet Alert
09/30/2021FOLDBuy Now
Amicus Therapeutics
$5.73109.42%
Joseph Schwartz64%
$13 → $12MaintainsMarket PerformGet Alert
09/20/2021PTGXBuy Now
Protagonist Therapeutics
$53.92-35.09%
Joseph Schwartz64%
$50 → $35MaintainsOutperformGet Alert
08/26/2021ASNDBuy Now
Ascendis Pharma
$170.716.61%
Joseph Schwartz64%
$178 → $182MaintainsOutperformGet Alert
08/17/2021TVTXBuy Now
Travere Therapeutics
$13.93165.61%
Joseph Schwartz64%
$27 → $37MaintainsOutperformGet Alert
08/13/2021FULCBuy Now
Fulcrum Therapeutics
$6.80444.12%
Joseph Schwartz64%
$23 → $37MaintainsOutperformGet Alert
08/10/2021GOSSBuy Now
Gossamer Bio
$1.291062.79%
Joseph Schwartz64%
$19 → $15MaintainsOutperformGet Alert
08/05/2021PTGXBuy Now
Protagonist Therapeutics
$53.92-7.27%
Joseph Schwartz64%
$41 → $50MaintainsOutperformGet Alert
07/21/2021ASNDBuy Now
Ascendis Pharma
$170.714.27%
Joseph Schwartz64%
$181 → $178MaintainsOutperformGet Alert
06/14/2021ASNDBuy Now
Ascendis Pharma
$170.716.03%
Joseph Schwartz64%
$191 → $181MaintainsOutperformGet Alert
05/07/2021ARNABuy Now
Arena Pharmaceuticals
——
Joseph Schwartz64%
$90 → $112MaintainsOutperformGet Alert
05/07/2021CCXIBuy Now
ChemoCentryx
——
Joseph Schwartz64%
$84 → $17DowngradeOutperform → Market PerformGet Alert
05/04/2021RPHMBuy Now
Reneo Pharmaceuticals
——
Joseph Schwartz64%
→ $25Initiates → OutperformGet Alert
04/20/2021EWTXBuy Now
Edgewise Therapeutics
$14.47134.97%
Joseph Schwartz64%
→ $34Initiates → OutperformGet Alert
04/20/2021DSGNBuy Now
Design Therapeutics
$3.94813.71%
Joseph Schwartz64%
→ $36Initiates → OutperformGet Alert
03/22/2021FOLDBuy Now
Amicus Therapeutics
$5.73126.88%
Joseph Schwartz64%
$15 → $13MaintainsMarket PerformGet Alert
03/16/2021SLDBBuy Now
Solid Biosciences
$4.80212.5%
Joseph Schwartz64%
$3 → $15UpgradeMarket Perform → OutperformGet Alert
03/08/2021IMRABuy Now
Imara
——
Joseph Schwartz64%
$59 → $42MaintainsOutperformGet Alert
03/03/2021PTGXBuy Now
Protagonist Therapeutics
$53.92-23.96%
Joseph Schwartz64%
$30 → $41MaintainsOutperformGet Alert
03/02/2021PHVSBuy Now
Pharvaris
$16.56201.93%
Joseph Schwartz64%
→ $50Initiates → OutperformGet Alert
03/02/2021SRPTBuy Now
Sarepta Therapeutics
$20.65510.17%
Joseph Schwartz64%
$125 → $126MaintainsOutperformGet Alert
02/24/2021ARNABuy Now
Arena Pharmaceuticals
——
Joseph Schwartz64%
$92 → $90MaintainsOutperformGet Alert
02/22/2021AMTIBuy Now
Applied Molecular
——
Joseph Schwartz64%
$32 → $74MaintainsOutperformGet Alert
02/16/2021RAREBuy Now
Ultragenyx Pharmaceutical
$37.35376.57%
Joseph Schwartz64%
$115 → $178MaintainsOutperformGet Alert
02/12/2021FOLDBuy Now
Amicus Therapeutics
$5.73161.78%
Joseph Schwartz64%
$30 → $15DowngradeOutperform → Market PerformGet Alert
02/10/2021KALVBuy Now
KalVista Pharma
$12.33313.63%
Joseph Schwartz64%
$39 → $51MaintainsOutperformGet Alert
01/27/2021AUPHBuy Now
Aurinia Pharmaceuticals
$7.92253.54%
Joseph Schwartz64%
$24 → $28MaintainsOutperformGet Alert
01/08/2021SRPTBuy Now
Sarepta Therapeutics
$20.65505.33%
Joseph Schwartz64%
$197 → $125MaintainsOutperformGet Alert
01/04/2021INSMBuy Now
Insmed
$99.46-44.7%
Joseph Schwartz64%
$51 → $55MaintainsOutperformGet Alert
12/14/2020FOLDBuy Now
Amicus Therapeutics
$5.73423.56%
Joseph Schwartz64%
$24 → $30MaintainsOutperformGet Alert
11/17/2020KALVBuy Now
KalVista Pharma
$12.33216.3%
Joseph Schwartz64%
$28 → $39MaintainsOutperformGet Alert
11/12/2020ASNDBuy Now
Ascendis Pharma
$170.7111.89%
Joseph Schwartz64%
$173 → $191MaintainsOutperformGet Alert
11/10/2020FULCBuy Now
Fulcrum Therapeutics
$6.80238.24%
Joseph Schwartz64%
$25 → $23MaintainsOutperformGet Alert
11/10/2020ARNABuy Now
Arena Pharmaceuticals
——
Joseph Schwartz64%
$91 → $92MaintainsOutperformGet Alert
11/06/2020BMRNBuy Now
Biomarin Pharmaceutical
$55.2895.37%
Joseph Schwartz64%
$113 → $108Reiterates → OutperformGet Alert
11/06/2020IFRXBuy Now
InflaRx
$0.771197.86%
Joseph Schwartz64%
$7 → $10UpgradeMarket Perform → OutperformGet Alert
11/06/2020FOLDBuy Now
Amicus Therapeutics
$5.73318.85%
Joseph Schwartz64%
$19 → $24MaintainsOutperformGet Alert
11/06/2020SRPTBuy Now
Sarepta Therapeutics
$20.65854%
Joseph Schwartz64%
$214 → $197MaintainsOutperformGet Alert
11/03/2020SPRBBuy Now
Spruce Biosciences
$0.0843650%
Joseph Schwartz64%
→ $35Initiates → OutperformGet Alert
10/29/2020CCXIBuy Now
ChemoCentryx
——
Joseph Schwartz64%
$75 → $84MaintainsOutperformGet Alert
10/28/2020RAREBuy Now
Ultragenyx Pharmaceutical
$37.35207.9%
Joseph Schwartz64%
$110 → $115MaintainsOutperformGet Alert
10/13/2020GOSSBuy Now
Gossamer Bio
$1.292148.06%
Joseph Schwartz64%
$36 → $29MaintainsOutperformGet Alert
10/07/2020KDNYBuy Now
Chinook Therapeutics
——
Joseph Schwartz64%
→ $38Initiates → OutperformGet Alert
08/19/2020BMRNBuy Now
Biomarin Pharmaceutical
$55.28104.41%
Joseph Schwartz64%
$140 → $113MaintainsOutperformGet Alert
08/06/2020ARNABuy Now
Arena Pharmaceuticals
——
Joseph Schwartz64%
$73 → $91MaintainsOutperformGet Alert
08/05/2020BMRNBuy Now
Biomarin Pharmaceutical
$55.28153.26%
Joseph Schwartz64%
$130 → $140MaintainsOutperformGet Alert
07/07/2020RNABuy Now
Avidity Biosciences
$28.8924.61%
Joseph Schwartz64%
→ $36Initiates → OutperformGet Alert
06/30/2020AMTIBuy Now
Applied Molecular
——
Joseph Schwartz64%
→ $32Initiates → OutperformGet Alert
06/12/2020IMRABuy Now
Imara
——
Joseph Schwartz64%
$27 → $64MaintainsOutperformGet Alert
05/22/2020PTGXBuy Now
Protagonist Therapeutics
$53.92-44.36%
Joseph Schwartz64%
$17 → $30MaintainsOutperformGet Alert
05/20/2020ASNDBuy Now
Ascendis Pharma
$170.711.34%
Joseph Schwartz64%
$170 → $173MaintainsOutperformGet Alert
05/20/2020GOSSBuy Now
Gossamer Bio
$1.292690.7%
Joseph Schwartz64%
$27 → $36Reiterates → OutperformGet Alert
05/12/2020CCXIBuy Now
ChemoCentryx
——
Joseph Schwartz64%
$54 → $65Reiterates → OutperformGet Alert
05/08/2020IMRABuy Now
Imara
——
Joseph Schwartz64%
$25 → $27Reiterates → OutperformGet Alert
05/07/2020IFRXBuy Now
InflaRx
$0.77808.5%
Joseph Schwartz64%
$4 → $7MaintainsMarket PerformGet Alert
04/20/2020ASNDBuy Now
Ascendis Pharma
$170.71-0.42%
Joseph Schwartz64%
$152 → $170MaintainsOutperformGet Alert
04/06/2020IMRABuy Now
Imara
——
Joseph Schwartz64%
→ $25Initiates → OutperformGet Alert
08/19/2019SLDBBuy Now
Solid Biosciences
$4.80—
Joseph Schwartz64%
—UpgradeMarket Perform → OutperformGet Alert
03/05/2019GOSSBuy Now
Gossamer Bio
$1.29—
Joseph Schwartz64%
—Initiates → OutperformGet Alert
01/24/2019ASNDBuy Now
Ascendis Pharma
$170.71-47.28%
Joseph Schwartz64%
$73 → $90UpgradeMarket Perform → OutperformGet Alert
07/19/2018RAREBuy Now
Ultragenyx Pharmaceutical
$37.35154.35%
Joseph Schwartz64%
$68 → $95MaintainsOutperformGet Alert
06/20/2018SRPTBuy Now
Sarepta Therapeutics
$20.65849.15%
Joseph Schwartz64%
$121 → $196MaintainsOutperformGet Alert
03/13/2018SRPTBuy Now
Sarepta Therapeutics
$20.65345.52%
Joseph Schwartz64%
$79 → $92MaintainsOutperformGet Alert
02/23/2018BMRNBuy Now
Biomarin Pharmaceutical
$55.28138.78%
Joseph Schwartz64%
$142 → $132MaintainsOutperformGet Alert
02/08/2018FOLDBuy Now
Amicus Therapeutics
$5.73318.85%
Joseph Schwartz64%
$20 → $24MaintainsOutperformGet Alert
01/05/2018RGLSBuy Now
Regulus Therapeutics
$8.21-75.64%
Joseph Schwartz64%
→ $2Initiates → OutperformGet Alert
12/12/2017ONCEBuy Now
Spark Therapeutics
——
Joseph Schwartz64%
—DowngradeOutperform → Market PerformGet Alert
10/23/2017NITEBuy Now
Nightstar Therapeutics plc - American Depositary Shares
$29.81-16.13%
Joseph Schwartz64%
→ $25Initiates → OutperformGet Alert
10/23/2017AUPHBuy Now
Aurinia Pharmaceuticals
$7.9276.77%
Joseph Schwartz64%
$10 → $14MaintainsOutperformGet Alert
10/19/2017BMRNBuy Now
Biomarin Pharmaceutical
$55.28156.87%
Joseph Schwartz64%
$136 → $142MaintainsOutperformGet Alert
09/26/2017PRQRBuy Now
ProQR Therapeutics
$1.94518.56%
Joseph Schwartz64%
$10 → $12MaintainsOutperformGet Alert
09/19/2017SYBXBuy Now
Synlogic
$1.211966.12%
Joseph Schwartz64%
→ $25Initiates → OutperformGet Alert
09/13/2017RETABuy Now
Reata Pharmaceuticals
——
Joseph Schwartz64%
→ $43Initiates → OutperformGet Alert
08/28/2017CMTABuy Now
Clementia Pharmaceuticals Inc. - Common Shares
——
Joseph Schwartz64%
→ $23Initiates → OutperformGet Alert
05/19/2017ARNABuy Now
Arena Pharmaceuticals
——
Joseph Schwartz64%
→ $5Initiates → OutperformGet Alert
05/18/2017ACHNBuy Now
Achillion Pharmaceuticals
——
Joseph Schwartz64%
—UpgradeMarket Perform → OutperformGet Alert
03/09/2017ASNDBuy Now
Ascendis Pharma
$170.71-82.43%
Joseph Schwartz64%
$24 → $30DowngradeOutperform → Market PerformGet Alert
03/02/2017SRPTBuy Now
Sarepta Therapeutics
$20.65127.6%
Joseph Schwartz64%
$27 → $47UpgradeMarket Perform → OutperformGet Alert
02/09/2017ONCEBuy Now
Spark Therapeutics
——
Joseph Schwartz64%
→ $85Initiates → OutperformGet Alert
05/04/2016ACHNBuy Now
Achillion Pharmaceuticals
——
Joseph Schwartz64%
$7 → $9MaintainsMarket PerformGet Alert
05/02/2016SRPTBuy Now
Sarepta Therapeutics
$20.65-75.79%
Joseph Schwartz64%
$13 → $5DowngradeMarket Perform → UnderperformGet Alert
02/23/2016BMRNBuy Now
Biomarin Pharmaceutical
$55.28117.08%
Joseph Schwartz64%
$149 → $120MaintainsOutperformGet Alert
02/19/2016RAREBuy Now
Ultragenyx Pharmaceutical
$37.35114.19%
Joseph Schwartz64%
→ $80Initiates → OutperformGet Alert
01/29/2016ACHNBuy Now
Achillion Pharmaceuticals
——
Joseph Schwartz64%
—DowngradeOutperform → Market PerformGet Alert
11/06/2015SRPTBuy Now
Sarepta Therapeutics
$20.6530.75%
Joseph Schwartz64%
$33 → $27MaintainsMarket PerformGet Alert
10/05/2015FOLDBuy Now
Amicus Therapeutics
$5.73266.49%
Joseph Schwartz64%
$23 → $21MaintainsOutperformGet Alert
03/04/2015FOLDBuy Now
Amicus Therapeutics
$5.73126.88%
Joseph Schwartz64%
$9 → $13MaintainsOutperformGet Alert
02/23/2015ASNDBuy Now
Ascendis Pharma
$170.71-82.43%
Joseph Schwartz64%
→ $30Initiates → OutperformGet Alert
02/02/2015AUPHBuy Now
Aurinia Pharmaceuticals
$7.921.01%
Joseph Schwartz64%
→ $8Initiates → OutperformGet Alert
10/13/2014PRQRBuy Now
ProQR Therapeutics
$1.941137.11%
Joseph Schwartz64%
→ $24Initiates → OutperformGet Alert
07/01/2014FOLDBuy Now
Amicus Therapeutics
$5.734.71%
Joseph Schwartz64%
$2.5 → $6UpgradeMarket Perform → OutperformGet Alert
11/12/2013SRPTBuy Now
Sarepta Therapeutics
$20.65-17.68%
Joseph Schwartz64%
$44 → $17MaintainsMarket PerformGet Alert
10/24/2013FOLDBuy Now
Amicus Therapeutics
$5.73—
Joseph Schwartz64%
—Downgrade → Market PerformGet Alert
04/16/2013SRPTBuy Now
Sarepta Therapeutics
$20.65—
Joseph Schwartz64%
—DowngradeOutperform → Market PerformGet Alert
03/05/2013SRPTBuy Now
Sarepta Therapeutics
$20.65117.92%
Joseph Schwartz64%
→ $45Initiates → OutperformGet Alert
02/06/2013ARNABuy Now
Arena Pharmaceuticals
——
Joseph Schwartz64%
—Assumes → OutperformGet Alert